Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Scimitar Syndrome | 3 | 2021 | 52 | 2.010 |
Why?
|
Cardiac Surgical Procedures | 5 | 2022 | 1099 | 1.780 |
Why?
|
Vascular Surgical Procedures | 6 | 2024 | 565 | 1.700 |
Why?
|
Heart Transplantation | 3 | 2024 | 854 | 1.540 |
Why?
|
Aortic Coarctation | 2 | 2024 | 105 | 1.520 |
Why?
|
Tetralogy of Fallot | 3 | 2022 | 161 | 1.500 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2022 | 133 | 1.260 |
Why?
|
Aortic Valve Insufficiency | 2 | 2020 | 138 | 1.150 |
Why?
|
Aorta, Thoracic | 4 | 2024 | 517 | 1.060 |
Why?
|
Postoperative Complications | 5 | 2021 | 3011 | 0.990 |
Why?
|
Lower Urinary Tract Symptoms | 1 | 2024 | 30 | 0.880 |
Why?
|
Independent Living | 1 | 2024 | 65 | 0.870 |
Why?
|
Incidental Findings | 1 | 2024 | 124 | 0.850 |
Why?
|
Acute Kidney Injury | 2 | 2020 | 608 | 0.830 |
Why?
|
Embolism, Air | 1 | 2022 | 25 | 0.810 |
Why?
|
Pulmonary Veins | 2 | 2021 | 162 | 0.810 |
Why?
|
Fontan Procedure | 2 | 2022 | 182 | 0.810 |
Why?
|
Heart Septal Defects | 1 | 2022 | 40 | 0.800 |
Why?
|
Pulmonary Artery | 3 | 2022 | 438 | 0.780 |
Why?
|
Sutureless Surgical Procedures | 1 | 2021 | 7 | 0.780 |
Why?
|
Frailty | 1 | 2024 | 97 | 0.780 |
Why?
|
Replantation | 2 | 2022 | 54 | 0.780 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2021 | 28 | 0.760 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2018 | 792 | 0.730 |
Why?
|
Myosin Heavy Chains | 1 | 2021 | 77 | 0.730 |
Why?
|
Loeys-Dietz Syndrome | 1 | 2021 | 37 | 0.710 |
Why?
|
Coronary Stenosis | 1 | 2021 | 70 | 0.700 |
Why?
|
Coronary Vessel Anomalies | 1 | 2024 | 274 | 0.690 |
Why?
|
Lipocalin-2 | 1 | 2019 | 28 | 0.680 |
Why?
|
Heart Rate | 5 | 2018 | 585 | 0.680 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2019 | 29 | 0.680 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2018 | 660 | 0.660 |
Why?
|
Heart Valve Diseases | 2 | 2020 | 167 | 0.650 |
Why?
|
Coronary Vessels | 3 | 2024 | 526 | 0.650 |
Why?
|
Aortic Diseases | 1 | 2021 | 196 | 0.640 |
Why?
|
Heart Defects, Congenital | 2 | 2022 | 1801 | 0.630 |
Why?
|
Pericardium | 1 | 2019 | 82 | 0.620 |
Why?
|
Tachycardia, Ectopic Junctional | 1 | 2018 | 13 | 0.620 |
Why?
|
Aorta | 2 | 2021 | 541 | 0.610 |
Why?
|
Morpholines | 1 | 2018 | 56 | 0.610 |
Why?
|
Aortic Aneurysm | 1 | 2021 | 224 | 0.600 |
Why?
|
Therapeutic Irrigation | 1 | 2018 | 43 | 0.590 |
Why?
|
Organ Sparing Treatments | 1 | 2018 | 34 | 0.590 |
Why?
|
Arterial Switch Operation | 1 | 2018 | 22 | 0.590 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 366 | 0.580 |
Why?
|
Urea | 1 | 2018 | 210 | 0.580 |
Why?
|
Echocardiography | 5 | 2024 | 1062 | 0.570 |
Why?
|
Esophageal Stenosis | 1 | 2017 | 44 | 0.560 |
Why?
|
Deglutition | 1 | 2017 | 47 | 0.550 |
Why?
|
Infant | 9 | 2024 | 12334 | 0.550 |
Why?
|
Heart Valves | 1 | 2017 | 51 | 0.550 |
Why?
|
Carotid Artery, Common | 1 | 2017 | 73 | 0.550 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2018 | 234 | 0.540 |
Why?
|
Blood Vessel Prosthesis | 2 | 2018 | 530 | 0.540 |
Why?
|
Humans | 31 | 2024 | 123122 | 0.530 |
Why?
|
Thrombosis | 1 | 2021 | 520 | 0.530 |
Why?
|
Coronary Aneurysm | 1 | 2016 | 34 | 0.530 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 2044 | 0.530 |
Why?
|
Drainage | 1 | 2018 | 256 | 0.530 |
Why?
|
Hematoma | 1 | 2016 | 92 | 0.510 |
Why?
|
Aortic Rupture | 1 | 2017 | 118 | 0.510 |
Why?
|
Prosthesis-Related Infections | 1 | 2018 | 176 | 0.510 |
Why?
|
Deglutition Disorders | 1 | 2017 | 125 | 0.500 |
Why?
|
DNA | 1 | 2021 | 1592 | 0.500 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2019 | 313 | 0.480 |
Why?
|
Coronary Angiography | 1 | 2016 | 419 | 0.460 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2018 | 427 | 0.430 |
Why?
|
Male | 23 | 2024 | 60036 | 0.420 |
Why?
|
Japan | 3 | 2024 | 134 | 0.420 |
Why?
|
Mutation | 3 | 2023 | 5771 | 0.400 |
Why?
|
Endovascular Procedures | 2 | 2018 | 725 | 0.400 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2019 | 622 | 0.390 |
Why?
|
Azotobacter vinelandii | 1 | 2011 | 1 | 0.390 |
Why?
|
Siderophores | 1 | 2011 | 10 | 0.390 |
Why?
|
Molybdenum | 1 | 2011 | 16 | 0.390 |
Why?
|
Heart | 5 | 2022 | 725 | 0.370 |
Why?
|
Treatment Outcome | 7 | 2024 | 12121 | 0.370 |
Why?
|
Multigene Family | 1 | 2011 | 298 | 0.350 |
Why?
|
Alkynes | 3 | 2006 | 26 | 0.330 |
Why?
|
Time Factors | 4 | 2024 | 6204 | 0.320 |
Why?
|
Child, Preschool | 5 | 2024 | 13874 | 0.310 |
Why?
|
Adenosine | 3 | 2006 | 126 | 0.310 |
Why?
|
Child | 6 | 2024 | 24219 | 0.280 |
Why?
|
Coronary Circulation | 5 | 2006 | 210 | 0.260 |
Why?
|
Female | 17 | 2024 | 65443 | 0.250 |
Why?
|
Computed Tomography Angiography | 2 | 2017 | 195 | 0.250 |
Why?
|
Infant, Newborn | 4 | 2024 | 8101 | 0.240 |
Why?
|
Androgen Receptor Antagonists | 1 | 2024 | 33 | 0.240 |
Why?
|
Anilides | 1 | 2024 | 48 | 0.240 |
Why?
|
Aged | 5 | 2024 | 19072 | 0.240 |
Why?
|
Xerostomia | 1 | 2024 | 9 | 0.230 |
Why?
|
Nitriles | 1 | 2024 | 146 | 0.230 |
Why?
|
Abnormalities, Multiple | 2 | 2019 | 964 | 0.210 |
Why?
|
Bundle-Branch Block | 1 | 2022 | 35 | 0.200 |
Why?
|
Anastomosis, Surgical | 1 | 2022 | 169 | 0.200 |
Why?
|
Sutures | 1 | 2022 | 67 | 0.190 |
Why?
|
Perfusion | 1 | 2022 | 197 | 0.190 |
Why?
|
Mitral Valve | 2 | 2020 | 246 | 0.190 |
Why?
|
Biomarkers | 3 | 2020 | 2941 | 0.190 |
Why?
|
Severity of Illness Index | 2 | 2021 | 2837 | 0.190 |
Why?
|
Blood Pressure | 4 | 2018 | 1318 | 0.190 |
Why?
|
Prostheses and Implants | 1 | 2022 | 151 | 0.180 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 121 | 0.180 |
Why?
|
Suture Techniques | 1 | 2022 | 198 | 0.180 |
Why?
|
Tissue Donors | 1 | 2024 | 496 | 0.180 |
Why?
|
Device Removal | 1 | 2022 | 222 | 0.180 |
Why?
|
Heart Atria | 1 | 2022 | 312 | 0.170 |
Why?
|
Lipocalins | 1 | 2019 | 25 | 0.170 |
Why?
|
Glyburide | 4 | 1999 | 22 | 0.170 |
Why?
|
Purinergic P1 Receptor Agonists | 1 | 1999 | 5 | 0.170 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 424 | 0.160 |
Why?
|
Myocarditis | 1 | 2020 | 119 | 0.160 |
Why?
|
Organ Size | 1 | 2020 | 412 | 0.160 |
Why?
|
Pulmonary Atresia | 1 | 2019 | 48 | 0.160 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 793 | 0.160 |
Why?
|
Postoperative Period | 1 | 2019 | 330 | 0.160 |
Why?
|
Middle Aged | 4 | 2024 | 25971 | 0.160 |
Why?
|
Transplantation, Autologous | 1 | 2019 | 296 | 0.160 |
Why?
|
Reoperation | 1 | 2021 | 819 | 0.150 |
Why?
|
Mitral Valve Insufficiency | 1 | 2020 | 156 | 0.150 |
Why?
|
Retrospective Studies | 3 | 2024 | 16003 | 0.150 |
Why?
|
ROC Curve | 1 | 2019 | 556 | 0.150 |
Why?
|
Creatinine | 1 | 2019 | 380 | 0.150 |
Why?
|
Dilatation, Pathologic | 1 | 2018 | 93 | 0.150 |
Why?
|
Thoracoscopy | 1 | 2018 | 41 | 0.150 |
Why?
|
Aneurysm, Ruptured | 1 | 1998 | 36 | 0.150 |
Why?
|
Debridement | 1 | 2018 | 85 | 0.140 |
Why?
|
Cricoid Cartilage | 1 | 2017 | 16 | 0.140 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2019 | 141 | 0.140 |
Why?
|
Duodenum | 1 | 1998 | 98 | 0.140 |
Why?
|
Pancreas | 1 | 1998 | 210 | 0.140 |
Why?
|
Conservative Treatment | 1 | 2016 | 32 | 0.140 |
Why?
|
Genetic Testing | 1 | 2023 | 995 | 0.140 |
Why?
|
Aortography | 1 | 2017 | 200 | 0.130 |
Why?
|
Needles | 1 | 2016 | 51 | 0.130 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 1515 | 0.130 |
Why?
|
Echocardiography, Transesophageal | 1 | 2016 | 241 | 0.120 |
Why?
|
Embolization, Therapeutic | 1 | 1998 | 226 | 0.120 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 3379 | 0.120 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2018 | 252 | 0.120 |
Why?
|
Potassium Channels | 3 | 1994 | 157 | 0.120 |
Why?
|
Follow-Up Studies | 1 | 2024 | 5047 | 0.120 |
Why?
|
Dogs | 7 | 2006 | 765 | 0.120 |
Why?
|
Foreign Bodies | 1 | 2016 | 104 | 0.120 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2018 | 470 | 0.120 |
Why?
|
Adolescent | 3 | 2024 | 19091 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 1004 | 0.110 |
Why?
|
Calcium Channel Blockers | 2 | 1990 | 113 | 0.110 |
Why?
|
Receptors, Purinergic | 1 | 1992 | 16 | 0.100 |
Why?
|
Catechols | 1 | 2011 | 9 | 0.100 |
Why?
|
Stents | 1 | 2018 | 868 | 0.090 |
Why?
|
Guanidines | 2 | 2001 | 25 | 0.090 |
Why?
|
Culture Media | 1 | 2011 | 182 | 0.090 |
Why?
|
Gene Targeting | 1 | 2011 | 179 | 0.090 |
Why?
|
Genes, Bacterial | 1 | 2011 | 208 | 0.090 |
Why?
|
Age Factors | 1 | 2017 | 2799 | 0.090 |
Why?
|
Thiazoles | 1 | 1990 | 97 | 0.090 |
Why?
|
Pyridines | 2 | 2001 | 224 | 0.080 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2001 | 218 | 0.080 |
Why?
|
Iron | 1 | 2011 | 261 | 0.080 |
Why?
|
Peptides | 1 | 2011 | 794 | 0.070 |
Why?
|
Cardiotonic Agents | 2 | 2006 | 137 | 0.070 |
Why?
|
Myocardial Contraction | 3 | 1999 | 261 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 2396 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2006 | 1001 | 0.060 |
Why?
|
Aged, 80 and over | 1 | 2017 | 6373 | 0.060 |
Why?
|
Vasodilator Agents | 2 | 1999 | 203 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2006 | 102 | 0.060 |
Why?
|
Androstenes | 1 | 2024 | 4 | 0.060 |
Why?
|
Thiohydantoins | 1 | 2024 | 3 | 0.060 |
Why?
|
Phenylthiohydantoin | 1 | 2024 | 12 | 0.060 |
Why?
|
Tosyl Compounds | 1 | 2024 | 21 | 0.060 |
Why?
|
Flutamide | 1 | 2024 | 24 | 0.060 |
Why?
|
Heart Conduction System | 2 | 1999 | 145 | 0.060 |
Why?
|
Benzamides | 1 | 2024 | 107 | 0.060 |
Why?
|
Androgen Antagonists | 1 | 2024 | 114 | 0.060 |
Why?
|
Sodium-Hydrogen Exchangers | 2 | 2001 | 40 | 0.060 |
Why?
|
Risk Factors | 1 | 2017 | 10017 | 0.050 |
Why?
|
Niacinamide | 2 | 1994 | 24 | 0.050 |
Why?
|
Papillary Muscles | 2 | 1999 | 19 | 0.050 |
Why?
|
Health Care Costs | 1 | 2024 | 366 | 0.050 |
Why?
|
Myocardial Stunning | 1 | 2001 | 21 | 0.050 |
Why?
|
Chordae Tendineae | 1 | 2020 | 7 | 0.040 |
Why?
|
In Vitro Techniques | 2 | 1999 | 966 | 0.040 |
Why?
|
Atrioventricular Node | 1 | 1999 | 16 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1992 | 1681 | 0.040 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2000 | 144 | 0.040 |
Why?
|
Potassium Channel Blockers | 1 | 1999 | 83 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 1998 | 47 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 1999 | 448 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2000 | 334 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 1 | 2000 | 457 | 0.030 |
Why?
|
Catheterization | 1 | 1998 | 234 | 0.030 |
Why?
|
Animals | 8 | 2006 | 33708 | 0.030 |
Why?
|
Radiography | 1 | 1998 | 818 | 0.030 |
Why?
|
Norepinephrine | 2 | 1992 | 175 | 0.030 |
Why?
|
Hemodynamics | 2 | 2006 | 848 | 0.030 |
Why?
|
Fever | 1 | 2016 | 296 | 0.030 |
Why?
|
Inflammation | 1 | 2020 | 1402 | 0.030 |
Why?
|
Theophylline | 1 | 1992 | 29 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 1992 | 252 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 1990 | 16 | 0.020 |
Why?
|
Benzopyrans | 1 | 1990 | 19 | 0.020 |
Why?
|
Pyrroles | 1 | 1990 | 178 | 0.020 |
Why?
|
Myocardium | 2 | 2006 | 984 | 0.020 |
Why?
|
Receptors, Adenosine A2 | 1 | 2006 | 3 | 0.020 |
Why?
|
Creatine Kinase | 1 | 2006 | 54 | 0.020 |
Why?
|
Ischemic Preconditioning | 1 | 2006 | 17 | 0.020 |
Why?
|
Necrosis | 1 | 2006 | 204 | 0.020 |
Why?
|
Nicorandil | 2 | 1994 | 2 | 0.010 |
Why?
|
Aconitine | 1 | 2000 | 9 | 0.010 |
Why?
|
Sulfones | 1 | 2000 | 67 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2001 | 424 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2000 | 359 | 0.010 |
Why?
|
Depression, Chemical | 1 | 1994 | 43 | 0.010 |
Why?
|
Rats | 1 | 2000 | 3631 | 0.010 |
Why?
|
Drug Interactions | 1 | 1994 | 254 | 0.010 |
Why?
|
Cromakalim | 1 | 1990 | 2 | 0.010 |
Why?
|
Diltiazem | 1 | 1990 | 13 | 0.010 |
Why?
|
Anesthesia, Spinal | 1 | 1990 | 9 | 0.010 |
Why?
|
Nitroglycerin | 1 | 1990 | 23 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2000 | 4267 | 0.010 |
Why?
|